WisdomTree offers investors emerging markets exposure across seven different ETFs. In two of our portfolios, we took increased steps to lower our China risks and give more tools to investors who want diversified emerging markets exposure. Jeremy Schwartz and Matt Wagner discuss the portfolio characteristics of one of these Funds, the WisdomTree Emerging Markets Quality Dividend Growth Fund (DGRE).
Read the article
Golden shares, which give the holder 1% of equity and one board seat, have recently been used by the Chinese government to maintain control of certain private enterprises. Liqian Ren explores the history of golden shares, their current use in China and which sectors the government is likely to continue to exert control over.
Read the article
Some investors may want to access the China reopening theme without the volatility of investing directly in Chinese equities, which can be rife with existential geopolitical risk. Hyun Kang and Matt Wagner highlight our Japan Hedged Equity Fund and Europe Hedged Equity Fund as potential solutions for investors.
Read the article
Following the reversal of China’s Zero Covid policy, Liqian Ren looks at what China experienced in 2022 and how that could shed light on future policies.
Read the article
We recently rebalanced our ex-State-Owned Enterprises China Index (CHXSOE). Liqian Ren highlights three major changes.
Read the article
Unlike the Federal Reserve, the People’s Bank of China (PBoC) has a relatively high degree of freedom. Currently, the U.S. and China are on opposite sides of the monetary cycle, with the Fed tightening and the PBoC easing. Liqian Ren outlines the PBoC’s monetary framework and discusses its monetary easing cycle.
